Former Chief Financial Officer (7) · Insight Molecular Diagnostics Inc. (IMDX)

Anish John

A named executive officer of Insight Molecular Diagnostics in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$449,161

Salary $147,138Stock awards $0

FY2022: $738,162

3rd of 4 named executive officers at Insight Molecular Diagnostics by FY2023 total.

4 named officers on file for Insight Molecular Diagnostics, FY2023

Anish John’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Insight Molecular Diagnostics’s whole pay program stands against its peers

  • Insight Molecular Diagnostics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IMDX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Anish John’s full pay file as a PDF — free

More than this page: up to 10 years of Anish’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Anish John compensation by year

Insight Molecular Diagnostics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Insight Molecular Diagnostics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$285,962$147,138
Bonus$98,835$0
Stock awards$145,500$0
Option awards$189,606$97,198
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$18,259$204,826
Total$738,162$449,161

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Insight Molecular Diagnostics Inc. DEF 14A filed April 29, 2024, accession 0001493152-24-017052, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Insight Molecular Diagnostics Inc. filed document, accession 0001493152-24-017052. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

$738K
$449K
FY22
FY23
SalaryBonusStock awardsOption awardsAll other

Insight Molecular Diagnostics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Joshua RiggsPresident and Chief Executive Officer (3)$724,910
Ekkehard SchützChief Science Officer (15)$575,167
Anish John · this pageFormer Chief Financial Officer (7)$449,161
James LiuController and Principal Accounting Officer (12)$304,513

The full Insight Molecular Diagnostics compensation record

free company brief

This page is one person within Insight Molecular Diagnostics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Insight Molecular Diagnostics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Anish John's compensation dossier · One-time report. No refunds.